Bladder Cancer Cell Invasion Is Enhanced by Cross-Talk with Fibroblasts Through Hepatocyte Growth Factor

Urology

Volumn 69, Issue 4, 2007, Pages 780-784

  Wang, Pengfei ^a   Nishitani, Masa Aki ^a   Tanimoto, Shuji ^a   Kishimoto, Tomoteru ^a   Fukumori, Tomoharu ^a   Takahashi, Masayuki ^a   Kanayama, Hiro Omi ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MATRIGEL; NEUTRALIZING ANTIBODY; POLYETHYLENE TEREPHTHALATE; SCATTER FACTOR; SCATTER FACTOR RECEPTOR;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER CELL; CANCER INVASION; CELL ASSAY; CELL CULTURE; CELL INVASION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EVALUATION; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; AGED, 80 AND OVER; CELL COMMUNICATION; FEMALE; FIBROBLASTS; HEPATOCYTE GROWTH FACTOR; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; TUMOR CELLS, CULTURED; URINARY BLADDER NEOPLASMS;

EID: 34147129882     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2007.01.063     Document Type: Article

References (30)

1. Aboseif S., El-Sakka A., Young P., et al. Mesenchymal reprogramming of adult human epithelial differentiation. Differentiation 65 (1999) 113-118
2. Elenbaas B., and Weinberg R.A. Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation. Exp Cell Res 264 (2001) 169-184
3. Mueller M.M., and Fusenig N.E. Friends or foes-bipolar effects of the tumour stroma in cancer. Nat Rev Cancer 4 (2004) 839-849
4. Bhowmick N.A., and Moses H.L. Tumor-stroma interactions. Curr Opin Genet Dev 15 (2005) 97-101
5. Birchmeier C., Birchmeier W., Gherardi E., et al. Met, metastasis, motility and more. Nat Rev Mol Cell Biol 4 (2003) 915-925
6. Matsumoto K., and Nakamura T. Hepatocyte growth factor and the Met system as a mediator of tumor-stromal interactions. Int J Cancer 119 (2006) 477-483
7. Bottaro D.P., Rubin J.S., Faletto D.L., et al. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 251 (1991) 802-804
8. Takayama H., LaRochelle W.J., Sharp R., et al. Diverse tumorigenesis associated with aberrant development in mice overexpressing hepatocyte growth factor/scatter factor. Proc Natl Acad Sci USA 94 (1997) 701-706
9. Yamashita J., Ogawa M., Yamashita S., et al. Immunoreactive hepatocyte growth factor is a strong and independent predictor of recurrence and survival in human breast cancer. Cancer Res 54 (1994) 1630-1633
10. Gohji K., Nomi M., Niitani Y., et al. Independent prognostic value of serum hepatocyte growth factor in bladder cancer. J Clin Oncol 18 (2000) 2963-2971
11. Seidel C., Borset M., Turesson I., et al., Nordic Myeloma Study Group. Elevated serum concentrations of hepatocyte growth factor in patients with multiple myeloma. Blood 91 (1998) 806-812
12. Taniguchi T., Kitamura M., Arai K., et al. Increase in the circulating level of hepatocyte growth factor in gastric cancer patients. Br J Cancer 75 (1997) 673-677
13. Rosen E.M., Joseph A., Jin L., et al. Urinary and tissue levels of scatter factor in transitional cell carcinoma of bladder. J Urol 157 (1997) 72-78
14. Ohashi M., Aizawa S., Ooka H., et al. A new human diploid cell strain, TIG-1, for the research on cellular aging. Exp Gerontol 15 (1980) 121-133
15. Hamasuna R., Kataoka H., Meng J.Y., et al. Reduced expression of hepatocyte growth factor activator inhibitor type-2/placental bikunin (HAI-2/PB) in human glioblastomas: implication for anti-invasive role of HAI-2/PB in glioblastoma cells. Int J Cancer 93 (2001) 339-345
16. Nakamura T., Matsumoto K., Kiritoshi A., et al. Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells: in vitro analysis of tumor-stromal interactions. Cancer Res 57 (1997) 3305-3313
17. Yoshida S., Harada T., Iwabe T., et al. Induction of hepatocyte growth factor in stromal cells by tumor-derived basic fibroblast growth factor enhances growth and invasion of endometrial cancer. J Clin Endocrinol Metab 87 (2002) 2376-2383
18. Jeffers M., Fiscella M., Webb C.P., et al. The mutationally activated Met receptor mediates motility and metastasis. Proc Natl Acad Sci USA 95 (1998) 14417-14422
19. Kermorgant S., Aparicio T., Dessirier V., et al. Hepatocyte growth factor induces colonic cancer cell invasiveness via enhanced motility and protease overproduction: evidence for PI3 kinase and PKC involvement. Carcinogenesis 22 (2001) 1035-1042
20. Curran S., and Murray G.I. Matrix metalloproteinases: molecular aspects of their roles in tumour invasion and metastasis. Eur J Cancer 36 (2000) 1621-1630
21. Monvoisin A., Bisson C., Si-Tayeb K., et al. Involvement of matrix metalloproteinase type-3 in hepatocyte growth factor-induced invasion of human hepatocellular carcinoma cells. Int J Cancer 97 (2002) 157-162
22. To Y., Dohi M., Matsumoto K., et al. A two-way interaction between hepatocyte growth factor and interleukin-6 in tissue invasion of lung cancer cell line. Am J Respir Cell Mol Biol 27 (2002) 220-226
23. Fenton J.I., Wolff M.S., Orth M.W., et al. Membrane-type matrix metalloproteinases mediate curcumin-induced cell migration in non-tumorigenic colon epithelial cells differing in Apc genotype. Carcinogenesis 23 (2002) 1065-1070
24. Grey A.M., Schor A.M., Rushton G., et al. Purification of the migration stimulating factor produced by fetal and breast cancer patient fibroblasts. Proc Natl Acad Sci USA 86 (1989) 2438-2442
25. Ito A., Nakajima S., Sasaguri Y., et al. Co-culture of human breast adenocarcinoma MCF-7 cells and human dermal fibroblasts enhances the production of matrix metalloproteinases 1, 2 and 3 in fibroblasts. Br J Cancer 71 (1995) 1039-1045
26. Iozzo R.V. Tumor stroma as a regulator of neoplastic behavior: agonistic and antagonistic elements embedded in the same connective tissue. Lab Invest 73 (1995) 157-160
27. Seslar S.P., Nakamura T., and Byers S.W. Regulation of fibroblast hepatocyte growth factor/scatter factor expression by human breast carcinoma cell lines and peptide growth factors. Cancer Res 53 (1993) 1233-1238
28. Cheng H.L., Trink B., Tzai T.S., et al. Overexpression of c-met as a prognostic indicator for transitional cell carcinoma of the urinary bladder: a comparison with p53 nuclear accumulation. J Clin Oncol 20 (2002) 1544-1550
29. Joseph A., Weiss G.H., Jin L., et al. Expression of scatter factor in human bladder carcinoma. J Natl Cancer Inst 87 (1995) 372-377
30. Bhowmick N.A., Neilson E.G., and Moses H.L. Stromal fibroblasts in cancer initiation and progression. Nature 432 (2004) 332-337